Literature DB >> 17161620

Specificity, selection and significance of gene amplifications in cancer.

Samuel Myllykangas1, Tom Böhling, Sakari Knuutila.   

Abstract

DNA copy number amplifications activate oncogenes and are found in the majority of advanced solid tumors. Cell-lineage specificity and oncogene affinity of DNA amplifications in cancer suggest that properties of precursor stem cells and selection pressure in the tissue micro-environment determine the genomic location of gene amplifications. Biological specificity and significance of gene amplifications make them potential targets for clinical applications. Here we discuss the specificity of non-randomly occurring DNA copy number amplifications as defining features for cancers, their selection in the tumor tissue, and significance in the clinical practice.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17161620     DOI: 10.1016/j.semcancer.2006.10.005

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  27 in total

1.  Bayesian clustering and feature selection for cancer tissue samples.

Authors:  Pekka Marttinen; Samuel Myllykangas; Jukka Corander
Journal:  BMC Bioinformatics       Date:  2009-03-18       Impact factor: 3.169

2.  A new role for cortactin in invadopodia: regulation of protease secretion.

Authors:  Emily S Clark; Alissa M Weaver
Journal:  Eur J Cell Biol       Date:  2008-03-14       Impact factor: 4.492

3.  Relationships linking amplification level to gene over-expression in gliomas.

Authors:  Nicolas Vogt; Anne Gibaud; Anna Almeida; Isabelle Ourliac-Garnier; Michelle Debatisse; Bernard Malfoy
Journal:  PLoS One       Date:  2010-12-08       Impact factor: 3.240

4.  Multiple pathways in the FGF signaling network are frequently deregulated by gene amplification in oral dysplasias.

Authors:  Ivy F L Tsui; Catherine F Poh; Cathie Garnis; Miriam P Rosin; Lewei Zhang; Wan L Lam
Journal:  Int J Cancer       Date:  2009-11-01       Impact factor: 7.396

5.  Genomic and clinical analyses of 2p24 and 12q13-q14 amplification in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group.

Authors:  Frederic G Barr; Fenghai Duan; Lynette M Smith; Donna Gustafson; Mandy Pitts; Sue Hammond; Julie M Gastier-Foster
Journal:  Genes Chromosomes Cancer       Date:  2009-08       Impact factor: 5.006

Review 6.  Cortactin in tumor invasiveness.

Authors:  Alissa M Weaver
Journal:  Cancer Lett       Date:  2008-04-10       Impact factor: 8.679

7.  Cortactin, another player in the Lyn signaling pathway, is over-expressed and alternatively spliced in leukemic cells from patients with B-cell chronic lymphocytic leukemia.

Authors:  Cristina Gattazzo; Veronica Martini; Federica Frezzato; Valentina Trimarco; Elena Tibaldi; Monica Castelli; Monica Facco; Francesca Zonta; Anna Maria Brunati; Renato Zambello; Gianpietro Semenzato; Livio Trentin
Journal:  Haematologica       Date:  2014-02-14       Impact factor: 9.941

8.  Serine hydroxymethyltransferase 2 expression promotes tumorigenesis in rhabdomyosarcoma with 12q13-q14 amplification.

Authors:  Thanh H Nguyen; Prasantha L Vemu; Gregory E Hoy; Salah Boudjadi; Bishwanath Chatterjee; Jack F Shern; Javed Khan; Wenyue Sun; Frederic G Barr
Journal:  J Clin Invest       Date:  2021-08-02       Impact factor: 14.808

9.  The landscape of somatic copy-number alteration across human cancers.

Authors:  Rameen Beroukhim; Craig H Mermel; Dale Porter; Guo Wei; Soumya Raychaudhuri; Jerry Donovan; Jordi Barretina; Jesse S Boehm; Jennifer Dobson; Mitsuyoshi Urashima; Kevin T Mc Henry; Reid M Pinchback; Azra H Ligon; Yoon-Jae Cho; Leila Haery; Heidi Greulich; Michael Reich; Wendy Winckler; Michael S Lawrence; Barbara A Weir; Kumiko E Tanaka; Derek Y Chiang; Adam J Bass; Alice Loo; Carter Hoffman; John Prensner; Ted Liefeld; Qing Gao; Derek Yecies; Sabina Signoretti; Elizabeth Maher; Frederic J Kaye; Hidefumi Sasaki; Joel E Tepper; Jonathan A Fletcher; Josep Tabernero; José Baselga; Ming-Sound Tsao; Francesca Demichelis; Mark A Rubin; Pasi A Janne; Mark J Daly; Carmelo Nucera; Ross L Levine; Benjamin L Ebert; Stacey Gabriel; Anil K Rustgi; Cristina R Antonescu; Marc Ladanyi; Anthony Letai; Levi A Garraway; Massimo Loda; David G Beer; Lawrence D True; Aikou Okamoto; Scott L Pomeroy; Samuel Singer; Todd R Golub; Eric S Lander; Gad Getz; William R Sellers; Matthew Meyerson
Journal:  Nature       Date:  2010-02-18       Impact factor: 49.962

10.  Aggressiveness of HNSCC tumors depends on expression levels of cortactin, a gene in the 11q13 amplicon.

Authors:  E S Clark; B Brown; A S Whigham; A Kochaishvili; W G Yarbrough; A M Weaver
Journal:  Oncogene       Date:  2008-10-20       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.